Deborah Heart & Lung Center v. Virtua Health, Inc.
833 F.3d 399
3rd Cir.2016Background
- Deborah Heart and Lung Center (a charity hospital in Browns Mills, NJ) sued Virtua Health, Virtua Memorial Hospital Burlington County, and The Cardiology Group P.A. (CGPA) alleging Sherman Act §1 unlawful exclusive dealing that diverted advanced cardiac interventional (ACI) procedure referrals away from Deborah.
- Deborah defined the relevant product/geographic markets (undisputed below): emergency ACI market = three NJ counties; non-emergency ACI market = those three counties plus two additional NJ counties and parts of Philadelphia.
- CGPA historically referred many ACI patients to Deborah under physician-lease arrangements; beginning in 2005–2007 CGPA entered exclusivity arrangements (first with Virtua, later with Penn Presbyterian) that sharply reduced referrals to Deborah.
- Deborah alleged the new contracts with Penn Presbyterian (and Virtua’s role) unlawfully restrained trade and harmed competition by redirecting referrals and lowering Deborah’s market share/volume.
- The District Court granted summary judgment for defendants, concluding Deborah failed to show anticompetitive effects in the defined markets; the Third Circuit affirmed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Deborah showed anti-competitive effects under the rule of reason for its §1 exclusive-dealing claim | Deborah argued its evidence of reduced referrals and forced patient diversion (especially CGPA patients and Virtua ER entrants) demonstrated actual anticompetitive effects in the relevant market | Defendants argued effects were limited to a small subset of patients and did not show harm to competition in the market as a whole; Deborah never claimed defendants had market power | Held: Affirmed. Plaintiff must show anticompetitive effects in the market as a whole (or market power). Showing effects only on a small subset is insufficient. |
| Whether plaintiff could rely on defendant market power as a surrogate for actual effects | Deborah did not present a market-power theory below and could not rely on it on appeal | Defendants contended plaintiff waived any market-power theory and lacked evidence of market power | Held: Plaintiff waived market-power argument; evidence showed defendants lacked market power (small % of market cardiologists). |
| Whether the undisputed market definition limited plaintiff’s ability to show harm | Deborah conceded the market definition and presented evidence about only a narrow subset of that market | Defendants argued that Deborah’s concession meant it bore the burden to prove effects across that defined market | Held: Because Deborah accepted the broader market, it was bound by that definition and failed to show marketwide anticompetitive effects. |
| Whether Jefferson Parish or similar precedent allows showing harm by restricting choice for patients at a single hospital | Deborah relied on Jefferson Parish to argue injury to patient choice at particular hospitals sufficed | Defendants relied on Jefferson Parish holding that effects limited to one hospital did not show marketwide harm | Held: Jefferson Parish controls — anecdotal or single-hospital restrictions are insufficient absent marketwide effects. |
Key Cases Cited
- Gordon v. Lewistown Hosp., 423 F.3d 184 (3d Cir.) (four-prong antitrust plaintiff burden and summary judgment standard)
- ZF Meritor, LLC v. Eaton Corp., 696 F.3d 254 (3d Cir.) (rule-of-reason framework and exclusive-dealing standard)
- Angelico v. Lehigh Valley Hosp., Inc., 184 F.3d 268 (3d Cir.) (actual anticompetitive effects vs. market-power surrogate explanation)
- Eichorn v. AT&T Corp., 248 F.3d 131 (3d Cir.) (need to examine competitive significance in the defined market)
- Brader v. Allegheny Gen. Hosp., 64 F.3d 869 (3d Cir.) (rejection of single-hospital geographic market absent uniqueness)
- Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S. 2 (U.S.) (limitations on proving anticompetitive effects from single-hospital tying/restraints)